Waterloo, Iowa Clinical Trials

A listing of Waterloo, Iowa clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
Dissemination of the Cardiovascular Risk Service

The objective of this study is to evaluate the implementation of of a remote, pharmacist-led cardiovascular risk service (CVRS) in 12 large, organizationally and culturally diverse hospitals and health-systems, many with high proportions of minority and underserved patients.

hypertension
systolic blood pressure
diabetes
Northeast Iowa Family Practice Center
 (1.5 away) Contact site
  • 67 views
  • 11 Oct, 2020
  • +13 other locations
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of anamorelin HCl. Approximately 316 patients with advanced NSCLC with cachexia will be randomized 1:1 to anamorelin HCl 100 mg or placebo, taken orally once daily (QD) for a total of 24 weeks. Patients will be instructed to …

renal function
anamorelin hydrochloride
metastatic cancer
lung cancer
anamorelin
MercyOne Waterloo Cancer Center
 (1.5 away) Contact site
  • 197 views
  • 10 Sep, 2020
  • +71 other locations
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia

This phase III trial studies how well ibrutinib and obinutuzumab with or without venetoclax work in treating patients with chronic lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Obinutuzumab is a monoclonal antibody that may interfere with the …

antiretroviral agents
anemia
cyclin d1
night sweats
venetoclax
MercyOne Waterloo Medical Center
 (1.5 away) Contact site
  • 624 views
  • 25 Nov, 2020
  • +713 other locations
Testing The Addition of a New Anti-cancer Drug Venetoclax to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated Older Patients With Chronic Lymphocytic Leukemia

This phase III trial compares adding a new anti-cancer drug (venetoclax) to the usual treatment (ibrutinib plus obinutuzumab) in older patients with chronic lymphocytic leukemia who have not received previous treatment. The addition of venetoclax to the usual treatment might prevent chronic lymphocytic leukemia from returning. This trial also will …

platelet count
neutrophil count
anemia
rituximab
night sweats
MercyOne Waterloo Medical Center
 (1.5 away) Contact site
  • 374 views
  • 25 Nov, 2020
  • +652 other locations
Testing the Addition of a New Anti-cancer Drug Venetoclax to Usual Chemotherapy for High Grade B-cell Lymphomas

This phase II/III trial tests whether it is possible to decrease the chance of high-grade B-cell lymphomas returning or getting worse by adding a new drug, venetoclax to the usual combination of drugs used for treatment. Venetoclax may stop the growth of cancer cells by blocking a protein called Bcl-2. …

platelet count
neutrophil count
doxorubicin
rituximab
b-cell lymphoma
MercyOne Waterloo Medical Center
 (2.7 away) Contact site
  • 168 views
  • 25 Nov, 2020
  • +495 other locations
Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monitoring

A study evaluating the impact of remotely collected data, measured using digital technologies, on the use of guideline-recommended heart failure therapy in adult participants with heart failure.

ejection fraction
chronic heart failure
Research Site
 (2.7 away) Contact site
  • 2 views
  • 26 Oct, 2020
  • +2 other locations